statistiche ricercatore

NOLASCO, SANTI

Distribuzione geografica

Continente	#
NA - Nord America	1.178
AS - Asia	1.101
EU - Europa	891
AF - Africa	147
SA - Sud America	124
OC - Oceania	2
Totale	3.443

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	1.122
SG - Singapore	430
RU - Federazione Russa	371
CN - Cina	357
IT - Italia	314
KR - Corea	102
BR - Brasile	101
CI - Costa d'Avorio	78
VN - Vietnam	59
BD - Bangladesh	52
FR - Francia	46
CA - Canada	31
GB - Regno Unito	29
IE - Irlanda	27
IN - India	27
NL - Olanda	24
SN - Senegal	20
FI - Finlandia	19
NG - Nigeria	17
MX - Messico	14
JP - Giappone	13
HK - Hong Kong	12
DE - Germania	11
ES - Italia	9
PL - Polonia	9
BJ - Benin	8
TR - Turchia	8
ZA - Sudafrica	8
IQ - Iraq	7
KE - Kenya	7
EC - Ecuador	6
IR - Iran	6
PH - Filippine	5
VE - Venezuela	5
AR - Argentina	4
AT - Austria	4
CH - Svizzera	4
LT - Lituania	4
SE - Svezia	4
GR - Grecia	3
HU - Ungheria	3
IL - Israele	3
JO - Giordania	3
MY - Malesia	3
PY - Paraguay	3
AE - Emirati Arabi Uniti	2
AU - Australia	2
CR - Costa Rica	2
DK - Danimarca	2
DO - Repubblica Dominicana	2
EG - Egitto	2
ET - Etiopia	2
ID - Indonesia	2
MA - Marocco	2
OM - Oman	2
PT - Portogallo	2
TT - Trinidad e Tobago	2
TW - Taiwan	2
AL - Albania	1
BB - Barbados	1
BE - Belgio	1
BG - Bulgaria	1
BO - Bolivia	1
CL - Cile	1
CO - Colombia	1
DZ - Algeria	1
GA - Gabon	1
GE - Georgia	1
GT - Guatemala	1
GY - Guiana	1
JM - Giamaica	1
PA - Panama	1
PE - Perù	1
PK - Pakistan	1
PR - Porto Rico	1
PS - Palestinian Territory	1
RO - Romania	1
SA - Arabia Saudita	1
SI - Slovenia	1
SY - Repubblica araba siriana	1
TN - Tunisia	1
UA - Ucraina	1
UZ - Uzbekistan	1
Totale	3.443

Salva come PNG Salva come JPEG

Città	#
Singapore	290
Santa Clara	196
Hefei	190
Dallas	186
Moscow	156
San Jose	125
Seoul	101
Ashburn	98
Abidjan	78
Los Angeles	58
Beijing	47
Chicago	44
Civitanova Marche	36
Boardman	34
Lauterbourg	31
Council Bluffs	29
Milan	29
Dublin	27
Ho Chi Minh City	26
New York	26
Buffalo	21
Catania	20
Dakar	20
Rome	17
Orem	15
Lagos	14
São Paulo	14
Lappeenranta	12
Montreal	12
Naples	12
Palermo	12
Amsterdam	10
Bari	9
Brooklyn	9
Hanoi	9
Cotonou	8
Johannesburg	8
Messina	8
Tokyo	8
Bologna	7
Chennai	7
Hong Kong	7
Phoenix	7
Toronto	7
Warsaw	7
Biancavilla	6
Kochi	6
London	6
Turin	6
Amiens	5
Atlanta	5
Charlotte	5
Manchester	5
Militello in Val di Catania	5
Pune	5
Querétaro	5
Rimini	5
Seattle	5
Aci Catena	4
Denver	4
Fortaleza	4
Helsinki	4
Mexico City	4
Munich	4
Poplar	4
Salvador	4
Stockholm	4
Treviso	4
Verona	4
Abuja	3
Amman	3
Ankara	3
Astoria	3
Baghdad	3
Boydton	3
Cagliari	3
Costabissara	3
Genoa	3
Giarre	3
Houston	3
Madrid	3
Mascalucia	3
Paris	3
Praia Grande	3
Reggio Emilia	3
Rio de Janeiro	3
San Francisco	3
Tehran	3
Abbiategrasso	2
Addis Ababa	2
Athens	2
Bitonto	2
Biên Hòa	2
Botucatu	2
Bruneck	2
Campinas	2
Caracas	2
Corato	2
Corsico	2
Da Nang	2
Totale	2.281

Salva come PNG Salva come JPEG

Nome	#
High-Flow Nasal Cannula Oxygen Therapy: Physiological Mechanisms and Clinical Applications in Children	176
Acute and long-term management of severe bronchiectasis with high flow nasal therapy: A case report	149
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study	136
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study	134
Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study	131
Long-Term Domiciliary High-Flow Nasal Therapy in Patients with Bronchiectasis: A Preliminary Retrospective Observational Case-Control Study	127
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study	127
Type 2-High Severe Asthma with and without Bronchiectasis: A Prospective Observational Multicentre Study	123
Depemokimab, the first ultra-long-acting anti-IL-5 monoclonal antibody for severe eosinophilic asthma	121
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial	119
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience	118
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps	115
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis	112
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma treated with Mepolizumab: The REMI-M study	110
Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission	104
Long-Term High-Flow Nasal Therapy in Patients with Bronchiectasis of Different Severity: A Retrospective Cohort Study	102
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super‐Response and Remission With Mepolizumab	102
Eosinophilic Bronchiectasis: Prevalence, Severity, and Associated Features—A Cohort Study	100
Personalized Medicine in Asthma: Current Approach and Future Perspectives	97
Are we overlooking the lung function in the definition of severe asthma remission?	97
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study	90
Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis	88
“The Kafka’s Disease”	87
Impact of Long-Term High-Flow Nasal Therapy on Mucus Plugs in Patients with Bronchiectasis	84
Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression	82
Tezepelumab for asthma	82
Effectiveness of Mepolizumab on Mucus Plug Reduction and Clinical Outcomes in Severe Eosinophilic Asthma: A Prospective Observational Study	81
Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy	81
Comparability of asthma control test scores between self and physician-administered test	81
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program	73
Can humidified high flow reverse mucus plugging?	69
Advancing Clinical Remission in Severe Asthma: Efficacy of a Comprehensive Management Strategy Guided by Airway Inflammometry and Bioimaging [Migliorare la remissione clinica nell'asma grave: Efficacia di una strategia di gestione completa guidata dall'infiammometria delle vie aeree e dal bioimaging]	59
Switching Biological Therapies in Severe Asthma	57
Effect of the Arg16Gly β2‐Adrenergic Receptor Polymorphism on Long‐Term Mepolizumab Response and Clinical Remission in Severe Eosinophilic Asthma: A Genotype‐Stratified, Multicenter Study	26
Short-Term Effects of Dupilumab in Eosinophilic COPD	16
High-flow nasal therapy vs conventional oxygen therapy in mild COVID-19 hypoxaemia: a Bayesian reanalysis of the COVID-HIGH Trial	15
Effectiveness of Mepolizumab on Mucus Plugs and Clinical Outcomes in Severe Eosinophilic Asthma with and without Coexisting Bronchiectasis: A Prospective Pilot Study	9
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study	5
Totale	3.485

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	10.873
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	10.873

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2022/2023	89	0	0	0	0	0	0	25	29	20	4	2	9
2023/2024	224	6	29	22	19	6	47	4	21	3	8	44	15
2024/2025	820	15	87	53	48	146	114	40	23	24	61	102	107
2025/2026	2.319	154	257	256	152	282	459	215	59	127	141	120	97
2026/2027	33	33	0	0	0	0	0	0	0	0	0	0	0
Totale													3.485